Underscoring the pathological importance of increased RhoA activity, we find that TRPV4 neuropathy mutant-induced axonal and dendritic degeneration can be rescued in vivo by genetic inhibition of the Drosophila RhoA ortholog Rho1. The gene discussed is TRPV4; the disease is neuropathy.